Attributes | Values |
---|
rdf:type
| |
Description
| - Atrial fibrillation is associated with significantly greater rates of morbidity and mortality, caused primarily by thromboembolic complications. The prevention of thromboembolic strokes is therefore one of the most important elements of the complex treatment of atrial fibrillation. Different strategies for anticoagulant or antiplatelet therapy in patients with atrial fibrillation are recommended for the prevention of thromboembolic complications according to the presentation of a different number of risk factors. New guidelines optimize antithrombotic treatment according to new risk stratification (CHA2DS2Vasc score) and mentioned the future of alternative antithrombotic treatment using direct thrombin antagonists or factor Xa inhibitors.
- Atrial fibrillation is associated with significantly greater rates of morbidity and mortality, caused primarily by thromboembolic complications. The prevention of thromboembolic strokes is therefore one of the most important elements of the complex treatment of atrial fibrillation. Different strategies for anticoagulant or antiplatelet therapy in patients with atrial fibrillation are recommended for the prevention of thromboembolic complications according to the presentation of a different number of risk factors. New guidelines optimize antithrombotic treatment according to new risk stratification (CHA2DS2Vasc score) and mentioned the future of alternative antithrombotic treatment using direct thrombin antagonists or factor Xa inhibitors. (en)
- Atrial fibrillation is associated with significantly greater rates of morbidity and mortality, caused primarily by thromboembolic complications. The prevention of thromboembolic strokes is therefore one of the most important elements of the complex treatment of atrial fibrillation. Different strategies for anticoagulant or antiplatelet therapy in patients with atrial fibrillation are recommended for the prevention of thromboembolic complications according to the presentation of a different number of risk factors. New guidelines optimize antithrombotic treatment according to new risk stratification (CHA2DS2Vasc score) and mentioned the future of alternative antithrombotic treatment using direct thrombin antagonists or factor Xa inhibitors. (cs)
|
Title
| - Antithrombotic treatment from the point of view of new guidelines for the management of atrial fibrillation (en)
- Antitrombotická léčba z pohledu nových doporučení pro léčbu nemocných s fibrilací síní
- Antitrombotická léčba z pohledu nových doporučení pro léčbu nemocných s fibrilací síní (cs)
|
skos:prefLabel
| - Antithrombotic treatment from the point of view of new guidelines for the management of atrial fibrillation (en)
- Antitrombotická léčba z pohledu nových doporučení pro léčbu nemocných s fibrilací síní
- Antitrombotická léčba z pohledu nových doporučení pro léčbu nemocných s fibrilací síní (cs)
|
skos:notation
| - RIV/00098892:_____/11:#0000185!RIV12-MZ0-00098892
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00098892:_____/11:#0000185
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - antithrombotic treatment , guidelines, atrial fibrillation (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Heinc, Petr
- Moravec, Ondřej
- Ondrušková, Jana
- Přeček, Jan
- Táborský, Miloš
|
issn
| |
number of pages
| |